
JADBio is an automated machine learning (AutoML) platform specializing in biomedical and multi-omics data analysis. Founded in 2019 and headquartered in Crete, Greece and Los Angeles, USA, it democratizes data science by enabling life-science professionals and data scientists to build accurate, explainable predictive models without programming expertise. The platform automates complex tasks such as feature selection, model tuning, and predictive performance evaluation, accelerating biomarker discovery and knowledge extraction in precision health and medicine. JADBio supports multi-omics data types including genomics, transcriptomics, proteomics, metabolomics, and clinical data, and offers off-the-shelf models for common healthcare use cases. It serves research teams and enterprises with flexible subscription plans and integrates with public and private data repositories, providing API access and advanced analytics capabilities. Trusted by partners like Indivumed and QIAGEN, JADBio is positioned as a leading AI tool for accelerating drug discovery and precision medicine research.

JADBio is an automated machine learning (AutoML) platform specializing in biomedical and multi-omics data analysis. Founded in 2019 and headquartered in Crete, Greece and Los Angeles, USA, it democratizes data science by enabling life-science professionals and data scientists to build accurate, explainable predictive models without programming expertise. The platform automates complex tasks such as feature selection, model tuning, and predictive performance evaluation, accelerating biomarker discovery and knowledge extraction in precision health and medicine. JADBio supports multi-omics data types including genomics, transcriptomics, proteomics, metabolomics, and clinical data, and offers off-the-shelf models for common healthcare use cases. It serves research teams and enterprises with flexible subscription plans and integrates with public and private data repositories, providing API access and advanced analytics capabilities. Trusted by partners like Indivumed and QIAGEN, JADBio is positioned as a leading AI tool for accelerating drug discovery and precision medicine research.
Product: No-code AutoML platform for biomedical and multi-omics data
Founded: 2019 (originating from a 2013 university spin-off)
Headquarters: Heraklion, Crete, Greece; Los Angeles, CA, USA
Use cases: Biomarker discovery, predictive modeling, feature selection for life-sciences
Funding signal: Multiple rounds reported; latest public round listed as Angel (June 10, 2020)
Biomedical data analysis, multi-omics integration, biomarker discovery, precision medicine
2019
Data and Analytics
Latest publicly listed round on Crunchbase
€150,000
ERC Proof of Concept grant reported to the CEO (non-dilutive)